Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Filgotinib in Active Non-Infectious Uveitis (Phase 2, Randomized, Placebo-Controlled)
2017-001485-17Phase 2Unknown
- Sponsor
- Gilead Sciences
- Start
- Jun 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in noninfectious uveitis (NIU) and Hyalitis comparing Filgotinib with Placebo (2 arms). Primary endpoint: Proportion of subjects failing treatment for active non-infectious uveitis by Week 24. Status: unknown.
02
Drugs
filgotinib
03
Conditions
noninfectious uveitis (NIU)Hyalitis
Beyond the preview
Go deeper on 2017-001485-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-001485-17.